लोड हो रहा है...
Activity of everolimus (RAD001) in relapsed and/or refractory multiple myeloma: a phase I study
The mammalian target of rapamycin plays an important role in multiple myeloma. The allosteric mammalian target of rapamycin inhibitor everolimus has long been approved for immunosuppression and has shown activity in certain cancers. This investigator-initiated phase I trial explored the use of evero...
में बचाया:
| में प्रकाशित: | Haematologica |
|---|---|
| मुख्य लेखकों: | , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
Ferrata Storti Foundation
2015
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4380728/ https://ncbi.nlm.nih.gov/pubmed/25682600 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2014.116269 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|